Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decreased HoxD10 Expression Promotes a Proliferative and Aggressive Phenotype in Prostate Cancer.

Current molecular medicine - 1 Jan 2017

Mo R-J, Lu J-M, Wan Y-P, Hua W, Liang Y-X, Zhuo Y-J, Kuang Q-W, Liu Y-L, He H-C, Zhong W-D

Abstract excerpt

HoxD10 gene plays a critical role in cell proliferation in the process of tumor development. However, the protein expression level and the function of HoxD10 in prostate cancer remain unknown. Using tissue microarray, we demonstrate that the protein expression of HoxD10 is commonly decreased in prostate cancer tissues (n = 92) compared to adjacent benign prostate tissues (n = 77). Functionally, knockdown of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Cycle
Share to Heterografts
Share to Homeodomain Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Grading

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Prostatic Neoplasms

Share to RNA, Small Interfering

Source

Identifiers

PMID: 28231752
DOI: 10.2174/1566524017666170220104920

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decreased HoxD10 Expression Promotes a Proliferative and Aggressive Phenotype in Prostate Cancer.PMID 28231752Read ↗

HOXD13 suppresses prostate cancer metastasis and BMP4 ‐induced epithelial‐mesenchymal transition by inhibiting SMAD1Semantic proximity Read ↗

Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancerSemantic proximity Read ↗

Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancerSemantic proximity Read ↗

Differential expression of CD10 in prostate cancer and its clinical implication.Semantic proximity Read ↗

Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancerSemantic proximity Read ↗

UBE2M promotes malignant phenotypes of prostate cancer through mediating NAA10 neddylation.Semantic proximity Read ↗

POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer.Semantic proximity Read ↗

HOXA13 is associated with unfavorable survival and acts as a novel oncogene in prostate carcinoma.Semantic proximity Read ↗

Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells.Semantic proximity Read ↗

DNA Methylation and the HOXC6 Paradox in Prostate CancerSemantic proximity Read ↗

HOXC8 Inhibits Androgen Receptor Signaling in Human Prostate Cancer Cells by Inhibiting SRC-3 Recruitment to Direct Androgen Target GenesSemantic proximity Read ↗

Overexpression of the homeobox gene <i>HOXC</i>8 in human prostate cancer correlates with loss of tumor differentiation*Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.